Monitor the outcome of the shareholder vote on May 5, 2026. If Impactive succeeds in placing its nominees on the board, it could lead to significant changes in WEX's strategy, potentially including a breakup of the company or other 'financial engineering' moves. The ongoing conflict and regulatory scrutiny could also create near-term uncertainty.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 6 $156.37entry
- T+1 · 7mo ago +0.56%α +0.50% · $157.25
- T+5 · 7mo ago +6.12%α +1.99% · $165.94
- T+20 · 7mo ago −1.45%α −10.43% · $154.11
- T+60 · 5mo ago −8.81%α −21.99% · $142.59
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
WEX Inc. is engaged in a proxy fight with activist investor Impactive Capital, which is seeking to replace three board members. WEX's board strongly opposes the nomination of Impactive's lead candidate, Lauren Taylor Wolfe, citing concerns about her conduct, conflicts of interest, and lack of alignment with long-term shareholders. The board urges shareholders to vote for its nine nominees.
Key Financial Metrics
Key Facts
- Impactive Capital is seeking to replace three of WEX's nine board directors with its own nominees.
- WEX's board opposes the nomination of Impactive's lead candidate, Lauren Taylor Wolfe, due to concerns about her conduct on other boards, conflicts of interest (her husband runs a VC firm invested in WEX competitor Ramp), and misalignment with long-term shareholders.
- WEX's board unanimously recommends voting for its nine nominees and has offered to expand the board and appoint two of Impactive's other nominees, but Impactive rejected this proposal.
- Impactive has sold over $100 million of WEX stock in the past year, reducing its position by approximately 30%.
Financial Impact
Potential board control change and strategic direction shift
Risk Factors
- Proxy fight could distract management from business operations.
- Regulatory issues: Impactive may need bank regulator approval due to WEX's banking subsidiary, and failure to obtain it could invalidate votes.
- Potential for strategic changes if Impactive gains board seats, which could include breaking up the company.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001213900-26-040160 |
| Document: 0001213900-26-040160-index-headers.html | 0001213900-26-040160 |
| Document: 0001213900-26-040160-index.html | 0001213900-26-040160 |
| Document: 0001213900-26-040160.txt | 0001213900-26-040160 |
Track record
26 reports on WEX
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +15.90% at T+20 after the Apr 13, 2026 report. 5 of 7 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $186.00 Now $184.83 −0.63% settles Feb 16
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $185.20 Now $184.83 −0.20% settles Feb 12
- Nov 12, 20264d ago Insider Cluster Bearish 5/10 Entry $181.53 Now $184.83 −1.82% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $179.49 Now $184.83 +2.98% settles Feb 10
- Nov 12, 20264d ago 8-K Neutral 4/10 Entry $179.49 Now $184.83 +2.98% settles Feb 10
- Nov 9, 20267d ago Insider Cluster Bearish 5/10 Entry $180.51 Now $184.83 −2.39% settles Feb 8
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $180.51 Now $184.83 +2.39% settles Feb 8
- Nov 6, 202610d ago 144 Bearish 5/10 Entry $182.53 Now $184.83 −1.26% settles Feb 5
- Nov 5, 202611d ago 144 Neutral 4/10 Entry $182.22 Now $184.83 +1.43% settles Feb 4
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $179.78 Now $184.83 +2.81% settles Feb 3
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers